| 000 | 01825 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518032731.0 | ||
| 264 | 0 | _c20200701 | |
| 008 | 202007s 0 0 eng d | ||
| 022 | _a1523-6536 | ||
| 024 | 7 |
_a10.1016/j.bbmt.2019.03.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNarayan, Rupa | |
| 245 | 0 | 0 |
_aDonor-Derived Cytokine-Induced Killer Cell Infusion as Consolidation after Nonmyeloablative Allogeneic Transplantation for Myeloid Neoplasms. _h[electronic resource] |
| 260 |
_bBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _c07 2019 |
||
| 300 |
_a1293-1303 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAllografts |
| 650 | 0 | 4 |
_aCytokine-Induced Killer Cells _xtransplantation |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xmortality |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xmortality |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTissue Donors |
| 700 | 1 | _aBenjamin, Jonathan E | |
| 700 | 1 | _aShah, Omid | |
| 700 | 1 | _aTian, Lu | |
| 700 | 1 | _aTate, Keri | |
| 700 | 1 | _aArmstrong, Randall | |
| 700 | 1 | _aXie, Bryan J | |
| 700 | 1 | _aLowsky, Robert | |
| 700 | 1 | _aLaport, Ginna | |
| 700 | 1 | _aNegrin, Robert S | |
| 700 | 1 | _aMeyer, Everett H | |
| 773 | 0 |
_tBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation _gvol. 25 _gno. 7 _gp. 1293-1303 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbmt.2019.03.027 _zAvailable from publisher's website |
| 999 |
_c29556218 _d29556218 |
||